Lineage Cell Therapeutics, Inc.
LCTX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000876343
No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Lineage Cell Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 131
- +3 vs. Q1 2026
- Shares held
- 116.5M
- +4.83M (+4.3%) vs. Q1 2026
- Total value
- $152.7M
- −$23.8M (−13.5%) vs. Q1 2026
- New holders
- 35
- 25 more added
- Sold out
- 32
- 29 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 131 | $152.7M |
| Q1 2026 | 130 | $176.5M |
| Q4 2025 | 123 | $169.8M |
| Q3 2025 | 112 | $148.6M |
| Q2 2025 | 129 | $88.4M |
| Q1 2025 | 127 | $49.7M |
| Q4 2024 | 126 | $53.8M |
| Q3 2024 | 114 | $85.6M |
| Q2 2024 | 113 | $94.2M |
| Q1 2024 | 116 | $138.3M |
| Q4 2023 | 115 | $82.5M |
| Q3 2023 | 104 | $89.1M |
| Q2 2023 | 107 | $106.6M |
| Q1 2023 | 116 | $104.7M |
| Q4 2022 | 106 | $76.2M |
| Q3 2022 | 104 | $73.1M |
| Q2 2022 | 100 | $102.7M |
| Q1 2022 | 109 | $112.3M |
| Q4 2021 | 124 | $182.0M |
| Q3 2021 | 115 | $191.7M |
| Q2 2021 | 115 | $208.5M |
| Q1 2021 | 102 | $141.8M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Lineage Cell Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 183,117 | $239.9K | 0.00% | +165,180+920.9% | Added |
| Deutsche Bank AG | 183,324 | $240.2K | 0.00% | +183,324 | New |
| FMR LLC | 192,926 | $252.7K | 0.00% | −382−0.2% | Reduced |
| McMillan Office, Inc. | 216,000 | $283.0K | 0.03% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 221,000 | $289.5K | 0.01% | 00.0% | Unchanged |
| Nuveen, LLC | 245,384 | $321.5K | 0.00% | +245,384 | New |
| Flputnam Investment Management Co | 304,562 | $399.0K | 0.00% | +304,562 | New |
| Bank of New York Mellon Corp | 391,675 | $513.1K | 0.00% | +368,462+1,587.3% | Added |
| Bank of America Corp | 424,373 | $555.9K | 0.00% | +5,018+1.2% | Added |
| Citadel Advisors LLC | 426,169 | $558.3K | 0.00% | +295,221+225.4% | Added |
| Goldman Sachs Group Inc | 433,266 | $567.6K | 0.00% | −736,161−63.0% | Reduced |
| Squarepoint Ops LLC | 444,774 | $582.7K | 0.00% | +301,584+210.6% | Added |
| Barclays PLC | 508,668 | $666.4K | 0.00% | +115,359+29.3% | Added |
| Charles Schwab Investment Management Inc | 577,435 | $756.4K | 0.00% | +447,511+344.4% | Added |
| Red Crane Wealth Management, LLC | 597,263 | $782.4K | 0.58% | 00.0% | Unchanged |
| UBS Group AG | 687,051 | $900.0K | 0.00% | −683,410−49.9% | Reduced |
| Vanguard Portfolio Management LLC | 1,273,311 | $1.67M | 0.00% | +1,273,311 | New |
| Marshall Wace, LLP | 1,282,347 | $1.68M | 0.00% | −1,782,686−58.2% | Reduced |
| Renaissance Technologies LLC | 1,344,829 | $1.76M | 0.00% | −780,271−36.7% | Reduced |
| Morgan Stanley | 1,471,462 | $1.93M | 0.00% | −397,029−21.2% | Reduced |
| Northern Trust Corp | 1,656,651 | $2.17M | 0.00% | +1,157,524+231.9% | Added |
| Vanguard Fiduciary Trust Co | 1,668,629 | $2.19M | 0.00% | +344,471+26.0% | Added |
| State Street Corp | 2,314,180 | $3.03M | 0.00% | +1,224,069+112.3% | Added |
| Millennium Management LLC | 3,018,567 | $3.95M | 0.00% | −2,542,807−45.7% | Reduced |
| Fifth Third Bancorp | 4,600,000 | $6.03M | 0.01% | 00.0% | Unchanged |
| Raffles Associates LP | 5,197,788 | $6.81M | 5.80% | −165,000−3.1% | Reduced |
| Geode Capital Management, LLC | 5,299,457 | $6.94M | 0.00% | +2,776,343+110.0% | Added |
| Defender Capital, LLC. | 6,598,899 | $8.64M | 2.81% | −130,700−1.9% | Reduced |
| Vanguard Capital Management LLC | 9,054,918 | $11.9M | 0.00% | +736,233+8.9% | Added |
| BlackRock, Inc. | 13,186,895 | $17.3M | 0.00% | +9,322,138+241.2% | Added |
| Broadwood Capital Inc | 49,560,992 | $64.9M | 3.39% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −3,182,799−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −422,274−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −346,615−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −304,363−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −259,561−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −232,264−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −186,794−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −185,061−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −170,300−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −122,051−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −111,287−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −109,000−100.0% | Sold out |
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −60,833−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −59,029−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −48,017−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −44,192−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −36,120−100.0% | Sold out |
| Golden State Equity Partners | 0 | $0 | 0.00% | −30,912−100.0% | Sold out |
| Nine Masts Capital Ltd | 0 | $0 | 0.00% | −29,194−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −21,160−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −21,157−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −20,029−100.0% | Sold out |
| Define Financial, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Catalytic Wealth RIA, LLC | 0 | $0 | 0.00% | −18,714−100.0% | Sold out |
| Quantessence Capital LLC | 0 | $0 | 0.00% | −16,281−100.0% | Sold out |
| CTC Alternative Strategies, Ltd. | 0 | $0 | 0.00% | −15,307−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −14,942−100.0% | Sold out |
| Stoneridge Investment Partners LLC | 0 | $0 | 0.00% | −12,540−100.0% | Sold out |
| Oxford Financial Group Ltd | 0 | $0 | 0.00% | −12,630−100.0% | Sold out |
| Scotia Capital Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −9,698−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |
| Sunbelt Securities, Inc. | – | – | – | – | Not filed |